Literature DB >> 15955957

Quantitative myasthenia gravis score: assessment of responsiveness and longitudinal validity.

R S Bedlack1, D L Simel, H Bosworth, G Samsa, B Tucker-Lipscomb, D B Sanders.   

Abstract

We prospectively tested the quantitative myasthenia gravis score (QMG) for responsiveness and longitudinal construct validity in 53 patients with myasthenia gravis. Index of responsiveness was high. Longitudinal construct validity was confirmed by the correlation between changes in QMG and manual muscle testing and by a difference in QMG changes across patients that were clinically unchanged, improved, or worse between two visits. Our results support QMG use for assessing clinical change in trials.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15955957     DOI： 10.1212/01.WNL.0000163988.28892.79

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  30 in total

1.  A crucial first randomized controlled trial of thymectomy in non-thymomatous myasthenia gravis.

Authors:  Pierre R Bourque; Jodi Warman Chardon
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

2.  Comparison of IVIg and PLEX in patients with myasthenia gravis.

Authors:  D Barth; M Nabavi Nouri; E Ng; P Nwe; V Bril
Journal:  Neurology       Date:  2011-05-11       Impact factor: 9.910

Review 3.  Precision medicine in myasthenia graves: begin from the data precision.

Authors:  Hai-Feng Li; Yu Hong; Yanchen Xie; Hong-Jun Hao; Ren-Cheng Sun
Journal:  Ann Transl Med       Date:  2016-03

4.  Artesunate for severe acute Plasmodium falciparum infection in a patient with myasthenia gravis.

Authors:  Nathalie Dournon; Pierre Buffet; Eric Caumes; Bernard Clair; Stéphane Jauréguiberry
Journal:  Am J Trop Med Hyg       Date:  2012-07-23       Impact factor: 2.345

5.  Changes of Treg-associated molecules on CD4+CD25 +Treg cells in myasthenia gravis and effects of immunosuppressants.

Authors:  Wen-Hua Xu; Ai-Mei Zhang; Ming-Shan Ren; Xu-Dong Zhang; Fang Wang; Xiu-Cai Xu; Qing Li; Jian Wang; Bang-Sheng Din; Yuan-Bo Wu; Gui-Hai Chen
Journal:  J Clin Immunol       Date:  2012-03-31       Impact factor: 8.317

6.  Minimal manifestation status and prednisone withdrawal in the MGTX trial.

Authors:  Ikjae Lee; Hui-Chien Kuo; Inmaculada B Aban; Gary R Cutter; Tarrant McPherson; Henry J Kaminski; Jon Sussman; Philipp Ströbel; Joel Oger; Gabriel Cea; Jeannine M Heckmann; Amelia Evoli; Wilfred Nix; Emma Ciafaloni; Giovanni Antonini; Rawiphan Witoonpanich; John O King; Said R Beydoun; Colin H Chalk; Alexandru C Barboi; Anthony A Amato; Aziz I Shaibani; Bashar Katirji; Bryan R F Lecky; Camilla Buckley; Angela Vincent; Elza Dias-Tosta; Hiroaki Yoshikawa; Marcia Waddington-Cruz; Michael T Pulley; Michael H Rivner; Anna Kostera-Pruszczyk; Robert M Pascuzzi; Carlayne E Jackson; Jan J G Verschuuren; Janice M Massey; John T Kissel; Lineu C Werneck; Michael Benatar; Richard J Barohn; Rup Tandan; Tahseen Mozaffar; Robin Conwit; Greg Minisman; Joshua R Sonett; Gil I Wolfe
Journal:  Neurology       Date:  2020-07-01       Impact factor: 9.910

7.  Randomized Trial of Thymectomy in Myasthenia Gravis.

Authors:  Gil I Wolfe; Henry J Kaminski; Inmaculada B Aban; Greg Minisman; Hui-Chien Kuo; Alexander Marx; Philipp Ströbel; Claudio Mazia; Joel Oger; J Gabriel Cea; Jeannine M Heckmann; Amelia Evoli; Wilfred Nix; Emma Ciafaloni; Giovanni Antonini; Rawiphan Witoonpanich; John O King; Said R Beydoun; Colin H Chalk; Alexandru C Barboi; Anthony A Amato; Aziz I Shaibani; Bashar Katirji; Bryan R F Lecky; Camilla Buckley; Angela Vincent; Elza Dias-Tosta; Hiroaki Yoshikawa; Márcia Waddington-Cruz; Michael T Pulley; Michael H Rivner; Anna Kostera-Pruszczyk; Robert M Pascuzzi; Carlayne E Jackson; Guillermo S Garcia Ramos; Jan J G M Verschuuren; Janice M Massey; John T Kissel; Lineu C Werneck; Michael Benatar; Richard J Barohn; Rup Tandan; Tahseen Mozaffar; Robin Conwit; Joanne Odenkirchen; Joshua R Sonett; Alfred Jaretzki; John Newsom-Davis; Gary R Cutter
Journal:  N Engl J Med       Date:  2016-08-11       Impact factor: 91.245

8.  Concordance between severity of disease, disability and health-related quality of life in myasthenia gravis.

Authors:  Alberto Raggi; Matilde Leonardi; Carlo Antozzi; Paolo Confalonieri; Lorenzo Maggi; Ferdinando Cornelio; Renato Mantegazza
Journal:  Neurol Sci       Date:  2009-10-09       Impact factor: 3.307

9.  Preoperative risk factors for prolonged postoperative ventilation following thymectomy in myasthenia gravis.

Authors:  Weihua Lu; Tao Yu; Federico Longhini; Xiaogan Jiang; Xuemei Qin; Xiaoju Jin
Journal:  Int J Clin Exp Med       Date:  2015-08-15

10.  International Workshop:: Outcome measures and clinical trial readiness in primary mitochondrial myopathies in children and adults. Consensus recommendations. 16-18 November 2016, Rome, Italy.

Authors:  Michelangelo Mancuso; Robert McFarland; Thomas Klopstock; Michio Hirano
Journal:  Neuromuscul Disord       Date:  2017-09-08       Impact factor: 4.296
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.